Tim M Govers
Overview
Explore the profile of Tim M Govers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
212
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prive B, Govers T, Israel B, Janssen M, Timmermans B, Peters S, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40072531
Background: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is currently under evaluation for detecting clinically significant prostate cancer. The PSMA-PET/CT may complement the current standard diagnostic pathway for...
2.
Metsemakers S, Metsemakers S, Hermens R, Hermens R, Ector G, Ector G, et al.
Value Health
. 2024 Dec;
28(2):224-232.
PMID: 39732165
Objectives: The management of chronic myeloid leukemia (CML) now includes dose reduction (DR) and treatment-free remission (TFR). Evaluating the cost-effectiveness of lifelong-prescribed expensive tyrosine kinase inhibitors (TKIs) for CML is...
3.
van Well E, Showalter T, Giannouli S, Nioutsikou E, Rovers M, Govers T
Brachytherapy
. 2024 Oct;
24(1):30-35.
PMID: 39443273
Purpose: Brachytherapy is associated with improved overall survival in cervical cancer patients, but the utilization seems hindered by high costs and relatively low reimbursement, particularly in the US. A one-room...
4.
Haraldsen I, Hatlestad-Hall C, Marra C, Renvall H, Maestu F, Acosta-Hernandez J, et al.
Front Neurorobot
. 2024 Jan;
17:1289406.
PMID: 38250599
More than 10 million Europeans show signs of mild cognitive impairment (MCI), a transitional stage between normal brain aging and dementia stage memory disorder. The path MCI takes can be...
5.
Govers T, Resnick M, Rastinehad A, Caba L, Groskopf J, Van Criekinge W
World J Urol
. 2023 May;
41(6):1527-1532.
PMID: 37133554
Purpose: The health impact and cost-effectiveness of the biomarker test SelectMDx were evaluated when used in combination with MRI, in two US populations: biopsy naïve men and men with a...
6.
Djodikromo M, Hermens R, van den Bemt B, Smit Y, Govers T, Bekker C, et al.
BMC Cancer
. 2023 Mar;
23(1):231.
PMID: 36899295
Background: Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness...
7.
van Asselt A, Armstrong N, Kimman M, Peeters A, McDermott K, Stirk L, et al.
Pharmacoeconomics
. 2023 Feb;
41(3):239-251.
PMID: 36725788
The National Institute for Health and Care Excellence invited the manufacturer (Galapagos) of filgotinib (Jyseleca), as part of the Single Technology Appraisal process, to submit evidence for the clinical effectiveness...
8.
Rovers M, Wijn S, Grutters J, Metsemakers S, Vermeulen R, van der Pennen R, et al.
BMJ Open
. 2022 Apr;
12(4):e054110.
PMID: 35396284
Objective: To develop a prioritisation framework to support priority setting for elective surgeries after COVID-19 based on the impact on patient well-being and cost. Design: We developed decision analytical models...
9.
van Leeuwen K, Meijer F, Schalekamp S, Rutten M, van Dijk E, van Ginneken B, et al.
Insights Imaging
. 2021 Sep;
12(1):133.
PMID: 34564764
Background: Limited evidence is available on the clinical impact of artificial intelligence (AI) in radiology. Early health technology assessment (HTA) is a methodology to assess the potential value of an...
10.
Burg L, Vermeulen R, Bekkers R, Wijn S, Rovers M, Govers T, et al.
Gynecol Oncol
. 2021 Feb;
161(1):251-260.
PMID: 33581847
Objective: To assess the cost-effectiveness of sentinel lymph node mapping compared to risk factor assessment and routine full lymph node dissection for the assessment of lymph nodes in patients with...